Vanda Pharmaceuticals (VNDA) Inventory (2012 - 2026)

Vanda Pharmaceuticals has reported Inventory for 15 years, with the latest figure at $1.7 million in Q1 2026.

• Quarterly Inventory fell 11.65% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 11.65% YoY) and the FY2025 annual result came in at $11.0 million, up 15.84% from the prior year.
• Inventory slipped to $1.7 million in Q1 2026 per VNDA's latest filing, from $11.0 million in the prior quarter.
• Over five years, Inventory peaked at $11.5 million in Q4 2022 and troughed at $1.3 million in Q1 2022.
• A 5-year average of $6.3 million and a median of $9.5 million in 2024 frame the typical range for Inventory.
• The widest YoY moves for Inventory: up 728.53% in 2023, down 88.19% in 2023.
• Over 5 years, Inventory stood at $11.5 million in 2022, then slumped by 88.19% to $1.4 million in 2023, then surged by 601.03% to $9.5 million in 2024, then advanced by 15.84% to $11.0 million in 2025, then tumbled by 84.58% to $1.7 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $1.7 million, $11.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.